Compare INSM & EWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INSM | EWBC |
|---|---|---|
| Founded | 1988 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 17.9B |
| IPO Year | 2000 | 1998 |
| Metric | INSM | EWBC |
|---|---|---|
| Price | $130.21 | $132.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 24 | 14 |
| Target Price | ★ $201.17 | $131.14 |
| AVG Volume (30 Days) | ★ 2.6M | 781.7K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | N/A | ★ 14.29 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $55,316,000.00 |
| Revenue This Year | $182.31 | $13.49 |
| Revenue Next Year | $65.19 | $5.78 |
| P/E Ratio | ★ N/A | $51.85 |
| Revenue Growth | N/A | ★ 3.12 |
| 52 Week Low | $90.39 | $92.67 |
| 52 Week High | $212.75 | $136.24 |
| Indicator | INSM | EWBC |
|---|---|---|
| Relative Strength Index (RSI) | 74.77 | 59.94 |
| Support Level | $105.07 | $126.13 |
| Resistance Level | $166.34 | $136.12 |
| Average True Range (ATR) | 3.25 | 2.05 |
| MACD | 1.12 | 0.03 |
| Stochastic Oscillator | 96.88 | 81.51 |
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
East West Bancorp Inc operates in U.S. and Asia. The Bank provides range of personal and commercial banking services to individuals and businesses. In addition to offering traditional deposit products that include personal and business checking and savings accounts, money market, and time deposits, the Bank also offers foreign exchange, treasury management and wealth management services. The Bank has three operating segments, (1) Consumer and Business Banking, (2) Commercial Banking and (3) Treasury and Other. The company generates the majority of its revenue from the Commercial banking segment.